NasdaqGS:OMCLMedical Equipment
Omnicell (OMCL) valuation check as new Titan XT automation platform targets healthcare growth
Omnicell (OMCL) just rolled out Titan XT, a new enterprise level automated dispensing system built on its OmniSphere cloud platform, and the launch is already reshaping how investors think about the stock.
See our latest analysis for Omnicell.
The launch of Titan XT coincides with Omnicell’s 30 day share price return of 30.11 percent and 90 day share price return of 51.10 percent, which signal rapidly building momentum. However, the 5 year total shareholder return of negative 60.02 percent...